These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 18775774

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample.
    Raison CL, Lin JM, Reeves WC.
    Brain Behav Immun; 2009 Mar; 23(3):327-37. PubMed ID: 19111923
    [Abstract] [Full Text] [Related]

  • 4. Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome.
    Van Den Eede F, Moorkens G, Van Houdenhove B, Cosyns P, Claes SJ.
    Neuropsychobiology; 2007 Mar; 55(2):112-20. PubMed ID: 17596739
    [Abstract] [Full Text] [Related]

  • 5. Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways.
    Morris G, Anderson G, Maes M.
    Mol Neurobiol; 2017 Nov; 54(9):6806-6819. PubMed ID: 27766535
    [Abstract] [Full Text] [Related]

  • 6. Biological indicators of illness risk in offspring of bipolar parents: targeting the hypothalamic-pituitary-adrenal axis and immune system.
    Duffy A, Lewitzka U, Doucette S, Andreazza A, Grof P.
    Early Interv Psychiatry; 2012 May; 6(2):128-37. PubMed ID: 22182213
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neuroendocrine aspects of chronic fatigue syndrome.
    Papanicolaou DA, Amsterdam JD, Levine S, McCann SM, Moore RC, Newbrand CH, Allen G, Nisenbaum R, Pfaff DW, Tsokos GC, Vgontzas AN, Kales A.
    Neuroimmunomodulation; 2004 May; 11(2):65-74. PubMed ID: 14758052
    [Abstract] [Full Text] [Related]

  • 9. Bayesian biomarker identification based on marker-expression proteomics data.
    Bhattacharjee M, Botting CH, Sillanpää MJ.
    Genomics; 2008 Dec; 92(6):384-92. PubMed ID: 18657605
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neuroaetiology of chronic fatigue syndrome: an overview.
    Sanders P, Korf J.
    World J Biol Psychiatry; 2008 Dec; 9(3):165-71. PubMed ID: 17853290
    [Abstract] [Full Text] [Related]

  • 12. Neuroendocrine dysfunction in Sjogren's syndrome.
    Tzioufas AG, Tsonis J, Moutsopoulos HM.
    Neuroimmunomodulation; 2008 Dec; 15(1):37-45. PubMed ID: 18667798
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chronic fatigue syndrome and high allostatic load: results from a population-based case-control study in Georgia.
    Maloney EM, Boneva R, Nater UM, Reeves WC.
    Psychosom Med; 2009 Jun; 71(5):549-56. PubMed ID: 19414615
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Research progress in the treatment of chronic fatigue syndrome through interventions targeting the hypothalamus-pituitary-adrenal axis.
    Zhang YD, Wang LN.
    Front Endocrinol (Lausanne); 2024 Jun; 15():1373748. PubMed ID: 38660512
    [Abstract] [Full Text] [Related]

  • 19. An integrated approach to infer causal associations among gene expression, genotype variation, and disease.
    Lee E, Cho S, Kim K, Park T.
    Genomics; 2009 Oct; 94(4):269-77. PubMed ID: 19540336
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.